TELEFLEX INCORPORATED
TFX · Healthcare · $5.9B mkt cap · FY2025 filings · Shallow moat ·
Doesn't clear the bar
The four filters
Median gross margin 54.7% over 10y, very stable.
Median ROIC 7.0%, above the 9% hurdle in 30% of years.
Net debt/EBITDA 7.6x, interest coverage 1x.
Owner earnings trend unclear, share count shrinking (buybacks).
Margin of safety
- Owner earnings (normalized)
- $458.0M
- Est. intrinsic value / share
- $115.13
- Recent price
- $134.61
- Discount to value
- 17% above value
Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).
19 years of fundamentals
The business, in plain English
TELEFLEX INCORPORATED booked $2.0B of revenue in FY2025 in the Healthcare sector and kept 56.2% of it as gross profit — a high-margin business by that measure. After every other cost, −45.4% of each revenue dollar reached the bottom line.
Across the filed record, revenue grew from $1.9B (FY2008) to $2.0B (FY2025) — about 0.2% a year compounded over 17 years.
It earned 2.2% on invested capital in FY2025, with a median of 7.5% across 18 filed years. The Returns on Capital filter above scores it 19/100.
The balance sheet carried $2.6B of total debt in FY2025. Balance-Sheet Safety scores it 0/100.
The share count rose 10.5% between FY2010 and FY2025 — existing owners have been diluted over the record. Capital Discipline scores it 47/100.
Put together: Pricing Power is the strongest of the four filters (89/100) and Balance-Sheet Safety the weakest (0/100), which is how TFX lands at 42/100 — a Shallow moat.
This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.
Gaps in a line mean that item isn’t in TFX’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.
Moat Score history
Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.
Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars
None yet — TFX has read Shallow moat for every logged capture since Jul 17, 2026.
Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.
Healthcare context
#217 of 440 scored Healthcare companies, ranked by Moat Score.
Nearest peers by Moat Score
- #215LITS Lite Strategy, Inc.42.0 out of 100, Shallow moatShallow moat
- #216MASS 908 DEVICES INC.42.0 out of 100, Shallow moatShallow moat
- #218OSUR ORASURE TECHNOLOGIES, INC41.7 out of 100, Shallow moatShallow moat
- #219VIVS VIVOSIM LABS, INC.41.7 out of 100, Shallow moatShallow moat
Compare TFX with its nearest peers →All Healthcare companies on the Index →
Common questions about TFX
- Does TELEFLEX INCORPORATED have an economic moat?
- Based on its FY2025 SEC filings, the Moat Index scores TELEFLEX INCORPORATED (TFX) 41.9 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 89, returns on capital 19, balance-sheet safety 0, capital discipline 47.
- Is TFX stock trading below its intrinsic value?
- Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $115.13 per share versus a recent price of $134.61 — 17% above value. This is an educational estimate computed from primary SEC filings, not investment advice.
- How has TFX's Moat Score changed over time?
- The record logs 3 readings since Jul 17, 2026; the latest reads 41.9 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.